Harte-Hanks (NASDAQ: HHS) reported Q4 EPS of $0.30, $0.22 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $39.86 million versus the consensus estimate of $55.6 million.

For earnings history and earnings-related data on Harte-Hanks (HHS) click here.